hormona glp 1 y gip Major physiological roles of GLP-1 and GIP. Tirzepatide is acting as an GIP and GLP-1 as incretin

People on GLP-1s medications or any caloric-deficit diet [can] face challenges such as nutrient deficiencies, reduced appetite, and muscle loss

Effects of sitagliptin on gastric emptying of, and the glycaemic and blood pressure responses to, a carbohydrate meal in type 2 diabetes

The non-homeostatic pathway differs between individuals because of variations in hormonal status, epigenetic markers and personal experiences

FFA1 receptor signaling increases GLP-1 secretion with or without chylomicron treatment, as shown with FFA1 agonist (AM-1638), FFA1 antagonist (GW110), and siRNA-mediated knockdown experiments in GLUTag cells (Psichas et al., 2017)

Studies varied widely in protocol (frequency, intensity, number of sessions), making it difficult to identify optimal parameters